Page last updated: 2024-09-04

nepafenac and Eye Disorders

nepafenac has been researched along with Eye Disorders in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cavanagh, HD; Maxwell, WA; Meuse, PA; Reiser, HJ; Sager, DP; Stewart, RH; Walters, TR	1
Cojocaru, I; Pop, A; Stefan, C	1
Hanemoto, T; Hayashi, K; Miyake, S; Miyata, K; Noge, S; Numaga, J; Saito, I; Yabe, N; Yata, K	1
Graff, G; Ke, TL; Spellman, JM; Yanni, JM	1

Reviews

1 review(s) available for nepafenac and Eye Disorders

Article	Year
[Progresses in antiinflamatory treatment in cataract surgery]. Oftalmologia (Bucharest, Romania : 1990), 2011, Volume: 55, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Drug Therapy, Combination; Eye Diseases; Glucocorticoids; Humans; Inflammation; Macular Edema; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Phenylacetates; Postoperative Care; Treatment Outcome	2011

Article

Year

[Progresses in antiinflamatory treatment in cataract surgery].

Oftalmologia (Bucharest, Romania : 1990), 2011, Volume: 55, Issue:3

Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Drug Therapy, Combination; Eye Diseases; Glucocorticoids; Humans; Inflammation; Macular Edema; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Phenylacetates; Postoperative Care; Treatment Outcome

2011

Trials

2 trial(s) available for nepafenac and Eye Disorders

Article	Year
Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Double-Blind Method; Drug Administration Schedule; Eye Diseases; Female; Humans; Inflammation; Male; Middle Aged; Pain, Postoperative; Phenylacetates; Prospective Studies; Treatment Failure	2008
[Phase III open-label study of nepafenac ophthalmic suspension 0.1% for inflammation and ocular pain following ophthalmic surgery]. Nippon Ganka Gakkai zasshi, 2012, Volume: 116, Issue:2 Topics: Adult; Aged; Benzeneacetamides; Eye Diseases; Eye Pain; Female; Humans; Inflammation; Male; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pain, Postoperative; Phenylacetates; Treatment Outcome	2012

Article

Year

Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:6

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Double-Blind Method; Drug Administration Schedule; Eye Diseases; Female; Humans; Inflammation; Male; Middle Aged; Pain, Postoperative; Phenylacetates; Prospective Studies; Treatment Failure

2008

[Phase III open-label study of nepafenac ophthalmic suspension 0.1% for inflammation and ocular pain following ophthalmic surgery].

Nippon Ganka Gakkai zasshi, 2012, Volume: 116, Issue:2

Topics: Adult; Aged; Benzeneacetamides; Eye Diseases; Eye Pain; Female; Humans; Inflammation; Male; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pain, Postoperative; Phenylacetates; Treatment Outcome

2012

Other Studies

1 other study(ies) available for nepafenac and Eye Disorders

Article	Year
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Inflammation, 2000, Volume: 24, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Biotransformation; Cornea; Diclofenac; Eye; Eye Diseases; Humans; In Vitro Techniques; Inflammation; Permeability; Phenylacetates; Prodrugs; Rabbits; Tissue Distribution	2000

Article

Year

Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.

Inflammation, 2000, Volume: 24, Issue:4

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Biotransformation; Cornea; Diclofenac; Eye; Eye Diseases; Humans; In Vitro Techniques; Inflammation; Permeability; Phenylacetates; Prodrugs; Rabbits; Tissue Distribution

2000